Mission
Bring cures to market faster.
The Gap
When the FDA approves a new treatment, it takes five months before physicians start prescribing it. Not because of regulatory delays— because 90% of pharmaceutical sales reps show up unprepared.
For patients with aggressive diseases where median survival is four months, that delay is a death sentence. Spellbinder eliminates that gap.
Our Approach
We've built the most complete physician-patient intelligence map in the United States by integrating 400+ datasets—prescription patterns, research publications, clinical trials, peer networks, hospital affiliations, and patient demographics.
Our AI tells reps not just what physicians prescribe, but why they prescribe it and what will resonate next. Zero setup. No IT integration. Works day one.
Our Team
We've spent our careers turning complex datasets into systems that create billions in value—building enterprise AI platforms, scaling products internationally, and driving outcomes at Fortune 500 companies.
The Future
We're building toward a world where no patient waits months for a treatment that could save their life. Where when a breakthrough happens anywhere in medicine, every relevant physician knows about it immediately.
A patient diagnosed with aggressive cancer won't lose precious weeks while their doctor learns about the treatment that could help them. Commercial success will happen faster, funding more R&D, creating more breakthroughs.